Close Menu
  • Home
  • Identity
  • Inventions
  • Future
  • Science
  • Startups
  • Spanish
What's Hot

Atomic imperatives for sustainable AI

Making ships greener, from fossil fuels to hydrogen technology

Malicious Vibe-coded VS Code extension with ransomware functionality discovered

Facebook X (Twitter) Instagram
  • Home
  • About Us
  • Advertise with Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
  • User-Submitted Posts
Facebook X (Twitter) Instagram
Fyself News
  • Home
  • Identity
  • Inventions
  • Future
  • Science
  • Startups
  • Spanish
Fyself News
Home » Perplexity signs multi-year licensing agreement with Getty Images
Startups

Perplexity signs multi-year licensing agreement with Getty Images

userBy userOctober 31, 2025No Comments3 Mins Read
Share Facebook Twitter Pinterest Telegram LinkedIn Tumblr Email Copy Link
Follow Us
Google News Flipboard
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link

AI search startup Perplexity has signed a multi-year licensing agreement with Getty Images, giving it permission to display Getty images across its AI-powered search and discovery tools. The deal marks a notable change for the company, which has been hit by allegations of content scraping and plagiarism, and signals an effort to establish more formal content partnerships.

Perplexity and Getty have been working together for more than a year, a person familiar with the deal told TechCrunch. Although it was never announced, Getty was participating in Perplexity’s Publishers Program and planned to share ad revenue with publishers when their content appeared in search queries, the people said.

Today’s agreement is a new agreement. Officials told TechCrunch that this is not a traditional block licensing deal because Perplexity does not train its own underlying models, but did not elaborate on the terms.

Perplexity’s agreement with Getty appears to legitimize some of the company’s previous uses of Getty’s stock photos. Perplexity came under fire last year for a series of plagiarism accusations from multiple news organizations. In one case, the startup was cited for extracting content from a Wall Street Journal article that included a photo of Getty.

At the time, some news outlets questioned whether Perplexity’s use of the images constituted copyright infringement. A source told TechCrunch last year that Perplexity was working on a deal with Getty, but could not confirm the deal despite multiple attempts to reach out to the stock image giant.

More recently, Reddit sued Perplexity in October, alleging “industrial scale and illegal” scraping of user content and circumvention of technological measures to access data. Reddit has a data licensing agreement with OpenAI.

Perplexity says its deal with Getty will improve the display of images and allow it to include a link to the original source in credit each time an image appears in search results.

Nick Unsworth, Getty’s vice president of strategic development, said the agreement “recognizes the importance of properly attributed consent and its value in powering AI-powered products.”

“Attribution and accuracy are fundamental to how people should understand the world in the age of AI,” Jessica Chan, head of content and publisher partnerships at Perplexity, said in a statement. “Together, we are helping people discover answers through powerful visual storytelling, while always knowing where their content comes from and who created it.”

Perplexity’s focus on attribution is part of its strategy to defend itself against copyright charges by arguing that since published facts are not copyrighted, use of publisher content (including content behind paywalls or where publishers have explicitly indicated they do not want scraping) constitutes “fair use.”


Source link

#Aceleradoras #CapitalRiesgo #EcosistemaStartup #Emprendimiento #InnovaciónEmpresarial #Startups
Follow on Google News Follow on Flipboard
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
Previous ArticleTim Cook says Apple is open to M&A in the AI ​​field
Next Article One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
user
  • Website

Related Posts

Tesla postpones mass production announcement of Roadster 2 to April Fools’ Day

November 6, 2025

Tesla shareholders approve Elon Musk’s $1 trillion compensation package

November 6, 2025

Sam Altman doesn’t want government to bail out OpenAI if it fails

November 6, 2025
Add A Comment
Leave A Reply Cancel Reply

Latest Posts

Atomic imperatives for sustainable AI

Making ships greener, from fossil fuels to hydrogen technology

Malicious Vibe-coded VS Code extension with ransomware functionality discovered

Tesla postpones mass production announcement of Roadster 2 to April Fools’ Day

Trending Posts

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Please enable JavaScript in your browser to complete this form.
Loading

Welcome to Fyself News, your go-to platform for the latest in tech, startups, inventions, sustainability, and fintech! We are a passionate team of enthusiasts committed to bringing you timely, insightful, and accurate information on the most pressing developments across these industries. Whether you’re an entrepreneur, investor, or just someone curious about the future of technology and innovation, Fyself News has something for you.

Meet Your Digital Twin: Europe’s Cutting-Edge AI is Personalizing Medicine

TwinH: The AI Game-Changer for Faster, More Accessible Legal Services

Immortality is No Longer Science Fiction: TwinH’s AI Breakthrough Could Change Everything

The AI Revolution: Beyond Superintelligence – TwinH Leads the Charge in Personalized, Secure Digital Identities

Facebook X (Twitter) Instagram Pinterest YouTube
  • Home
  • About Us
  • Advertise with Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
  • User-Submitted Posts
© 2025 news.fyself. Designed by by fyself.

Type above and press Enter to search. Press Esc to cancel.